Regulation of myeloma cell growth through Akt/Gsk3/forkhead signaling pathway

被引:25
|
作者
G-Amlak, M
Uddin, S
Mahmud, D
Damacela, I
Lavelle, D
Ahmed, M
van Besien, K
Wickrema, A
机构
[1] Univ Chicago, Hematol Oncol Sect, Chicago, IL 60637 USA
[2] Univ Illinois, Hematol Oncol Sect, Med Ctr, Chicago, IL 60607 USA
[3] W Side Vet Adm Med Ctr, Chicago, IL 60607 USA
关键词
myeloma; interleukin-6; glycogen synthase kinase 3; forkhead transcription factors; apoptosis;
D O I
10.1016/S0006-291X(02)02278-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The interleukin-6 (IL-6) signaling pathway contributes to myeloma cell growth and viability through activation of the PI3/Akt kinase pathway. To understand the downstream signaling elements in the PI3/Akt kinase pathway that are involved in the regulation of myeloma cell growth, we determined the role played by glycogen synthase kinase 3 (Gsk3) and forkhead transcription factors (FH) in the RPM1-8226 myeloma cell line. We demonstrate that both Gsk3 and FH transcription factors FKHRL1 (FOX3a), FKHR (FOXO1a), and AFX (FOXO4) are phosphorylated (inactivated) by IL-6. Further, we show that inhibitors of Gsk3 induce dephosphorylation of FKHRL1 and FKHR at their threonine sites and upregulate the cyclin-dependent kinase inhibitor p27(kipl). Finally, we show that inhibition of Gsk3 activity is sufficient to suppress cell growth and induce apoptosis thus overriding the effects of IL-6 in myeloma cells. (C) 2002 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:760 / 764
页数:5
相关论文
共 50 条
  • [31] The neuroprotection of cerebrolysin after spontaneous intracerebral hemorrhage through regulates necroptosis via Akt/GSK3β signaling pathway
    Tao, Yunna
    Xu, Yeping
    Shen, Meng
    Feng, Xiaoyan
    Wu, Yan
    Wu, Youping
    Shen, Liuyan
    Wang, Yuhai
    ACTA CIRURGICA BRASILEIRA, 2021, 36 (10)
  • [32] Ferrostatin-1 alleviates cerebral ischemia/reperfusion injury through activation of the AKT/GSK3? signaling pathway
    Liu, Xinyao
    Du, Yue
    Liu, Jian
    Cheng, Linggang
    He, Wen
    Zhang, Wei
    BRAIN RESEARCH BULLETIN, 2023, 193 : 146 - 157
  • [33] BMK1 Kinase Suppresses Epithelial-Mesenchymal Transition through the Akt/GSK3β Signaling Pathway
    Chen, Runqiang
    Yang, Qingkai
    Lee, Jiing-Dwan
    CANCER RESEARCH, 2012, 72 (06) : 1579 - 1587
  • [34] Andrographolide suppresses melanin synthesis through Akt/GSK3β/β-catenin signal pathway
    Zhu, Ping-Ya
    Yin, Wei-Han
    Wang, Meng-Ran
    Dang, Yong-Yan
    Ye, Xi-Yun
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2015, 79 (01) : 74 - 83
  • [35] Melatonin increases growth properties in human dermal papilla spheroids by activating AKT/GSK3β/β-Catenin signaling pathway
    Bae, Sowon
    Yoon, Yoo Gyeong
    Kim, Ji Yea
    Park, In-Chul
    An, Sungkwan
    Lee, Jae Ho
    Bae, Seunghee
    PEERJ, 2022, 10
  • [36] HMGA1 participates in MHCC97H cell proliferation and invasion through the ILK/Akt/GSK3β signaling pathway
    Liu, Li
    Zhang, Shuang
    Hu, Lei
    Liu, Linhua
    Guo, Wuhua
    Zhang, Jixiang
    MOLECULAR MEDICINE REPORTS, 2017, 16 (06) : 9287 - 9294
  • [37] Resveratrol activates the AKT/GSK3β pathway through up-regulation of MnSOD in doxorubin treated cardiac myocytes
    Skramsted, J
    Henry, N
    Balulad, S
    Bennett, J
    Keller, R
    FREE RADICAL BIOLOGY AND MEDICINE, 2004, 37 : S72 - S72
  • [38] LncRNA RNCR3 Promotes the Progression of HCC by Activating the Akt/GSK3β Signaling Pathway
    Xie, Qi
    Ju, Tongfa
    Zhou, Chunhua
    Zhai, Lulu
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2020, 2020
  • [39] Rhotekin 2 promotes progression of endometrial carcinoma by activating Akt/GSK3β signaling pathway
    Hu, Ting
    Wang, Min
    Zeng, Jing
    Wang, Xiaoli
    Gu, Hangzhi
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2021, 20 (05) : 917 - 924
  • [40] GSK3 signaling is critical to glioma stem cell growth and survival
    Alvarez, Angel
    Ugolkov, Andrey
    Gaisina, Irina
    Kozikowski, Alan P.
    Joshi, Kaushal
    Kim, Sunghak
    Nakano, Ichiro
    Raizer, Jeffrey J.
    Mazar, Andrew P.
    Hu, Bo
    Cheng, Shi-Yuan
    CANCER RESEARCH, 2014, 74 (19)